Articles with public access mandates - Roger A LevyLearn more
Not available anywhere: 2
14th international congress on antiphospholipid antibodies task force report on antiphospholipid syndrome treatment trends
D Erkan, CL Aguiar, D Andrade, H Cohen, MJ Cuadrado, A Danowski, ...
Autoimmunity reviews 13 (6), 685-696, 2014
Mandates: Versus Arthritis, UK
16th International congress on antiphospholipid antibodies task force report on clinical manifestations of antiphospholipid syndrome
S Sciascia, M Radin, I Cecchi, RA Levy, D Erkan
Lupus 30 (8), 1314-1326, 2021
Mandates: Government of Italy
Available somewhere: 18
Treat-to-target in systemic lupus erythematosus: recommendations from an international task force
RF Van Vollenhoven, M Mosca, G Bertsias, D Isenberg, A Kuhn, ...
Annals of the rheumatic diseases 73 (6), 958-967, 2014
Mandates: National Institute for Health Research, UK, Wellcome Trust
A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS)
R Van Vollenhoven, A Voskuyl, G Bertsias, C Aranow, M Aringer, ...
Annals of the rheumatic diseases 76 (3), 554-561, 2017
Mandates: UK Medical Research Council, National Institute for Health Research, UK
Improvements in health-related quality of life with belimumab, a B-lymphocyte stimulator-specific inhibitor, in patients with autoantibody-positive systemic lupus erythematosus …
V Strand, RA Levy, R Cervera, MA Petri, H Birch, WW Freimuth, ZJ Zhong, ...
Annals of the rheumatic diseases 73 (5), 838-844, 2014
Mandates: US National Institutes of Health
The effect of triple therapy on the mortality of catastrophic anti-phospholipid syndrome patients
I Rodríguez-Pintó, G Espinosa, D Erkan, Y Shoenfeld, R Cervera
Rheumatology 57 (7), 1264-1270, 2018
Mandates: US National Institutes of Health
Development of a new international antiphospholipid syndrome classification criteria phase I/II report: generation and reduction of candidate criteria
M Barbhaiya, S Zuily, Y Ahmadzadeh, MC Amigo, T Avcin, ...
Arthritis care & research 73 (10), 1490-1501, 2021
Mandates: US National Institutes of Health, British Heart Foundation
Factors associated with first thrombosis in patients presenting with obstetric antiphospholipid syndrome (APS) in the APS Alliance for Clinical Trials and International …
GR de Jesús, S Sciascia, D Andrade, M Barbhaiya, M Tektonidou, ...
BJOG: An International Journal of Obstetrics & Gynaecology 126 (5), 656-661, 2019
Mandates: US National Institutes of Health
Conceptual framework for defining disease modification in systemic lupus erythematosus: a call for formal criteria
R van Vollenhoven, AD Askanase, AS Bomback, IN Bruce, A Carroll, ...
Lupus science & medicine 9 (1), e000634, 2022
Mandates: National Institute for Health Research, UK
Characteristics of antiphospholipid antibody positive patients in antiphospholipid syndrome alliance for clinical trials and international networking
E Sevim, D Zisa, D Andrade, S Sciascia, V Pengo, MG Tektonidou, ...
Arthritis Care & Research 74 (2), 324-335, 2022
Mandates: US National Institutes of Health, Natural Sciences and Engineering Research …
Anti–neutrophil extracellular trap antibodies in antiphospholipid antibody–positive patients: results from the antiphospholipid syndrome alliance for clinical trials and …
Y Zuo, S Navaz, A Tsodikov, K Kmetova, L Kluge, A Ambati, CK Hoy, ...
Arthritis & Rheumatology 75 (8), 1407-1414, 2023
Mandates: US National Institutes of Health
Impact of belimumab on organ damage in systemic lupus erythematosus
Arthritis Care and Research, 2022
Mandates: US National Institutes of Health, National Institute for Health Research, UK
Global comment on the use of hydroxychloroquine during the periconception period and pregnancy in women with autoimmune diseases
K Schreiber, I Giles, N Costedoat-Chalumeau, C Nelson-Piercy, ...
The Lancet Rheumatology 5 (9), e501-e506, 2023
Mandates: Nordforsk
Belimumab versus anifrolumab in adults with systemic lupus erythematosus: an indirect comparison of clinical response at 52 weeks
B Neupane, P Shukla, M Slim, A Martin, M Petri, GK Bertsias, AHJ Kim, ...
Lupus Science & Medicine 10 (1), e000907, 2023
Mandates: US National Institutes of Health
Lupus spectrum ambiguity has long-term negative implications for patients
IN Bruce, J Buie, L Bloch, SC Bae, K Costenbader, RA Levy, VP Werth, ...
Lupus Science & Medicine 10 (1), e000856, 2023
Mandates: National Institute for Health Research, UK
Challenging cases in rheumatic pregnancies
C Edens, BC Rodrigues, MI Lacerda, FC Dos Santos, GR De Jesús, ...
Rheumatology 57 (suppl_5), v18-v25, 2018
Mandates: US National Institutes of Health
Associations among antiphospholipid antibody types, isotypes, and titers: an AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Study
E Gkrouzman, R Willis, D Andrade, MG Tektonidou, V Pengo, ...
Laboratory Investigation 103 (6), 100147, 2023
Mandates: US National Institutes of Health
Disease-modifying therapies in systemic lupus erythematosus for extrarenal manifestations
AD Askanase, RA Furie, M Dall'Era, AS Bomback, A Schwarting, MH Zhao, ...
Lupus Science & Medicine 11 (1), e001124, 2024
Mandates: National Institute for Health Research, UK
POS1153 applying the working definition of the disease modification criteria to systemic lupus erythematosus treatments from the published literature
A Askanase, R Furie, M Dall’Era, A Bomback, A Schwarting, MH Zhao, ...
Annals of the Rheumatic Diseases 82 (Suppl 1), 907-908, 2023
Mandates: National Institute for Health Research, UK
AB0531 APPLYING THE WORKING DEFINITION OF THE DISEASE MODIFICATION CRITERIA TO LUPUS NEPHRITIS TREATMENTS FROM THE PUBLISHED LITERATURE
A Askanase, R Furie, M Dall’era, A Bomback, A Schwarting, MH Zhao, ...
Annals of the Rheumatic Diseases 82 (Suppl 1), 1463-1464, 2023
Mandates: National Institute for Health Research, UK
Publication and funding information is determined automatically by a computer program